Oct 18, 2018 8:00am EDT Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033
Oct 16, 2018 8:00am EDT Matinas BioPharma to Present at the 8th Annual Partnership Opportunities in Drug Delivery Conference
Oct 15, 2018 8:01am EDT Matinas BioPharma Appoints Global Pharmaceutical Drug Development Industry Leader Theresa Matkovits, Ph.D., Chief Development Officer; Further Expands Manufacturing and Clinical Development Team
Sep 06, 2018 8:01am EDT Matinas BioPharma Announces Appointment of Industry Leader Patrick G. LePore to Board of Directors
Sep 05, 2018 8:00am EDT Matinas BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
Aug 16, 2018 8:00am EDT Matinas BioPharma to Present at the U.S. FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
Aug 10, 2018 8:15am EDT Matinas BioPharma Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Jul 09, 2018 9:15am EDT NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology
